Article
Researchers around the world have been working diligently over the last 25 years to develop artificial corneas for patients who are not good candidates for the current techniques of keratoplasty, according to Eduardo C. Alfonso, MD.
Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300
(EyePod) From idea to impact: Navigating ophthalmic innovation
Study explores the true costs of treating pediatric cataracts
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
Study: Aromatherapy decreased postoperative patient anxiety and pain associated with oculoplastic surgery
Raising cataract surgery procedure to an art and an experience